Artwork

Contenido proporcionado por Talking About Tumors. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Talking About Tumors o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

01_09 Metastatic Cholangiocarcinoma

23:31
 
Compartir
 

Manage episode 334645960 series 3335024
Contenido proporcionado por Talking About Tumors. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Talking About Tumors o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

1. Overview of nomenclature, etiology and presentation

2. Management of symptoms and prognosis

3. Systemic therapy in the first line

4. Second line and biomarker driven management

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references recommended to read related to this specific episode:

1. Marabelle A et al.. J Clin Oncol. 2020;38(1):1-10. doi:10.1200/JCO.19.02105

2. Lamarca A et al. The Lancet Oncology. 2021;22(5):690-701. doi:10.1016/S1470-2045

3. Zia MI, Siu LL, et al. Journal of Clinical Oncology. 2005;23(28):6982-6991. doi:10.1200/JCO.2005.06.679

4. Phelip JM et al. J Clin Oncol. 2022;40(3):262-271. doi:10.1200/JCO.21.00679

5. Valle J et al. NEJM. 2010;362(14):1273-1281. doi:10.1056/NEJMOA0908721

6. Oh DY et al. NEJM Evidence. Published online June 1, 2022. doi:https://doi.org/10.1056/EVIDoa2200015

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.

  continue reading

45 episodios

Artwork
iconCompartir
 
Manage episode 334645960 series 3335024
Contenido proporcionado por Talking About Tumors. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Talking About Tumors o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

1. Overview of nomenclature, etiology and presentation

2. Management of symptoms and prognosis

3. Systemic therapy in the first line

4. Second line and biomarker driven management

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references recommended to read related to this specific episode:

1. Marabelle A et al.. J Clin Oncol. 2020;38(1):1-10. doi:10.1200/JCO.19.02105

2. Lamarca A et al. The Lancet Oncology. 2021;22(5):690-701. doi:10.1016/S1470-2045

3. Zia MI, Siu LL, et al. Journal of Clinical Oncology. 2005;23(28):6982-6991. doi:10.1200/JCO.2005.06.679

4. Phelip JM et al. J Clin Oncol. 2022;40(3):262-271. doi:10.1200/JCO.21.00679

5. Valle J et al. NEJM. 2010;362(14):1273-1281. doi:10.1056/NEJMOA0908721

6. Oh DY et al. NEJM Evidence. Published online June 1, 2022. doi:https://doi.org/10.1056/EVIDoa2200015

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.

  continue reading

45 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida